Merck & Company, Inc. vs Zoetis Inc. — Stock Comparison
Merck & Company, Inc. (MRK) and Zoetis Inc. (ZTS) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Zoetis Inc. narrowly edges Merck & Company, Inc. on Q·Score (7.3 vs 7 out of 10), led by Quality (9.6 vs 7.7) and Valuation (8.6 vs 6.7). Merck & Company, Inc. scores higher on Growth, reflecting stronger revenue and earnings momentum. Analyst consensus targets imply greater upside for ZTS (+58.3%) than for MRK (+13.9%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 19% return on equity and 14% profit margins.
High-quality business with 68% return on equity and 28% profit margins.
⚠ limited growth momentum.
Analyst Consensus
Fundamentals
Frequently Asked Questions
MRK vs ZTS: which stock scores better overall?
Based on Q·Score, Zoetis Inc. (ZTS) scores 7.3/10 versus Merck & Company, Inc. (MRK) at 7/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: MRK or ZTS?
Merck & Company, Inc. (MRK) scores higher on Growth (6.2/10 vs 5.2/10). Merck & Company, Inc. reports revenue growth (4.9% YoY) while Zoetis Inc. reports (2.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is MRK or ZTS more attractively valued?
Zoetis Inc. (ZTS) scores higher on Valuation (8.6/10 vs 6.7/10). MRK trades at 11.9× P/E versus ZTS at 10.6×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about MRK vs ZTS?
There are 27 analysts covering MRK with a consensus price target of $129.74, and 17 analysts covering ZTS with a consensus target of $124.59. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: MRK or ZTS?
Zoetis Inc. (ZTS) scores higher on Quality (9.6/10 vs 7.7/10). Net profit margin: MRK at 13.6%, ZTS at 28.0%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: MRK or ZTS?
Merck & Company, Inc. (MRK) scores higher on Financial Health (7/10 vs 6.2/10). Market beta: MRK at 0.22, ZTS at 0.74. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of MRK and ZTS?
Merck & Company, Inc. (MRK) has a market capitalisation of $281.2B, while Zoetis Inc. (ZTS) has a market cap of $33.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do MRK or ZTS pay dividends?
MRK pays a dividend yield of 2.95%, while ZTS pays a dividend yield of 2.67%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →